Clinical Study
Plasma Vascular Endothelial Growth Factor Dysregulation in Defining Aggressiveness of Head and Neck Squamous Cell Carcinoma
Table 2
Plasma VEGF and sVEGFR-1 levels and VR secretion profile.
| Variable | Normal () | HNSCC () | |
| VEGF, pg/mL | | | | βMean (SD) | 41.7 (50.1) | 71.1 (133.7) | | βMedian (IQR) | 22.8 (14.5β38.1) | 29.4 (19.3β73.9) | 0.03 | sVEGFR-1, pg/mL | | | | βMean (SD) | 35.3 (30.1) | 45.1 (27.7) | | βMedian (IQR) | 27.9 (19.5β34) | 37.2 (29.8β54.3) | 0.0001 | VR secretion profile | | | 0.03 | β, (%) | 9 (28.1) | 11 (13.6) | | β, (%) | 8 (25) | 45 (54.9) | | β, (%) | 10 (31.3) | 17 (20.7) | | β, (%) | 5 (15.6) | 9 (11) | |
|
|